Digital Diabetes Management Market

Digital Diabetes Management Market Size (2022 to 2027)

As per our report, the size of the global digital diabetes management market is forecasted to grow at a CAGR of 23.32% over the forecast period and be worth USD 19.70 billion by 2027 and USD 6.91 billion in 2022. The North American region held the largest market share in 2020 due to increased awareness and government encouragement. On the other hand, the Asia Pacific digital diabetes management market grows at the fastest rate, while the European market has the next most significant share. 

Digital Diabetes Management Market Key Insights  :

• This report provides a detailed quantitative analysis of the current market and estimates for the years (2021 to 2026), which helps identify the prevailing market opportunities.
• Necessary changes in the digital diabetes management market dynamics.
• Report and evaluation of recent developments in the industry.
• Competitive intelligence helps to understand the competitive scenario in geographical regions.
• The key players in the market are described in detail in this report, and their strategies are analyzed in-depth to better understand the competitive advantage of the market.

MARKET DRIVERS

Y-O-Y growth in the prevalence of diabetes is the primary growth driver for the global digital diabetes management market.

Globally, the digital diabetes management market is mainly driven by the increasing number of diabetic patients worldwide. According to IDF (International Diabetes Federation), there were 463 million patients diagnosed with diabetes, and this figure is estimated to increase by 700 million by 2045.

Additionally, rising awareness over the treatment procedures among individuals in most areas, the growing prevalence of point of care testing devices that are accurate and convenient for the users are fuelling the market. Furthermore, the ever-increasing geriatric population base and the rapid shift towards digitization and digital solutions for medical problems are definite plus points driving the market growth.

Furthermore, the increase in the budgets being allotted for diabetic healthcare expenditure in emerging economies, the rise in support from the public and private organizations in developing various products favoring the end-users are likely to surge growth opportunities for the digital diabetes management market. In addition, the trend towards the adoption of advanced technologies and the growing geriatric population around the world are also significant factors influencing the growth of the market significantly.

MARKET RESTRAINTS

However, the high cost of these digital devices and the lack of reimbursed healthcare policies in developing countries are the major restraints. In addition, the lack of proper knowledge of the advanced technologies in rural areas is slowly restraining the demand of the business. Also, fewer skilled technicians in resolving the issues quickly in real-time applications are hampering the need for digital diabetes management.

COVID-19 impact on the global digital diabetes management market

Diabetes management is an essential healthcare area that demands regular care and attention. In a short period, the COVID-19 pandemic has significantly changed the digital healthcare industry. During the hard times of COVID-19, many diabetic patients have obtained digital solutions for diabetes management, which is added as a boost to the global market and has opened new growth possibilities.

REPORT COVERAGE:

This research report on the global digital diabetes management market has been segmented and sub-segmented based on type, products & services, end-user, and region. 

Digital Diabetes Management Market - By Type:

• Wearable Devices
• Handheld Devices

Based on type, the Wearable devices segment is predicted to dominate the global digital diabetes management market during the forecast period. Rising demand for the use of convenient devices and also highly reliable devices are lavishing the need for digital diabetes management. This segment is strongly driven by advanced technologies such as (AI) artificial intelligence, increasing acquisition of self-administering insulin delivery devices towards diabetes management, and introducing new products and devices like smart insulin patches and many more. These devices offer better services to people like accessibility, scalability, and the capability to get examined anywhere. Therefore, the handheld devices segment will have decent growth during the forecast period.

Digital Diabetes Management Market - By Product and Service:

• Devices
  • Smart Glucose Meters
  • Continuous Glucose Monitoring Systems
  • Smart Insulin Pens
  • Smart Insulin Pumps/Closed-Loop Systems and Smart Insulin Patches
• Applications
  • Digital Diabetes Management Apps
  • Diabetes and Blood Glucose Tracking Apps
  • Weight and Diet Management Apps
• Data Management Software and Platforms

• Services

Based on devices, the smart glucose meters segment is the most lucrative and expected to register healthy CAGR during the forecast period. The continuous glucose monitoring meters segment is expected to grow at a healthy CAGR during the forecast period due to their consistency with smart devices, which act as display devices, also favorable government policies in developed countries in promoting CGM systems. Furthermore, the smart insulin pens segment is to have lucrative possibilities to explore to the next level due to factors like the growing number of product launches related to the digital healthcare of AI.

Based on applications, diabetes & blood glucose tracking apps category dominates with the most significant shares of the market. The rise in the concern towards health care is escalating the demand of the market. The weight and diet management segment are expected to hold a considerable share of the market over the period, attributed to factors such as growing awareness about chronic diseases like diabetes and other difficulties related to it.

Digital Diabetes Management Market - By End-User:

• Individual/Home Healthcare
• Hospitals and Specialty Diabetes Clinics
• Academic and Research Institutes
• Others

Based on end-user, the Individual/home healthcare divisions segment is expected to dominate the global digital diabetes management market during the forecast period. In addition, the increasing prevalence of self-medication is leveraging the demand of the market.

Digital Diabetes Management Market - By Region:

• North America
• Europe
• Asia Pacific
• Latin America
• The Middle East and Africa

The North American digital diabetes management market was the most dominating regional market in the global digital diabetes management market in 2020. Increasing capital income in both developed and developing countries is majorly promoting the growth rate of the regional market. Within North America, the United States led the market in the recent past, and dominance is expected to continue during the foreseen period. However, the Canadian market is projected to perform well as the diabetic population in this country is growing at a significant pace.

The Asia Pacific digital diabetes management market was positioned second in gaining the majority of the share in the global market in 2020. Rising populations and the emergence of the latest technologies in the medical sector are escalating the market's growth. Growing support from the government by changing policies in favor of the ordinary people is gearing up the market's demand.

The European digital diabetes management market is forecasted to account for a substantial share in the global market during the forecast period due to the increasing number of research institutes to develop new devices.

The Middle East and Africa are deemed to have substantial growth opportunities in the coming years.

KEY MARKET PARTICIPANTS:

Leading companies operating in the global digital diabetes management market are Medtronic (Ireland), B. Braun (Germany), Dexcom (United States), Abbott Laboratories (United States), Roche Diagnostics (Switzerland), Insulet Corporation (United States), Tandem Diabetes Care (United States), Ascensia Diabetes Care (Switzerland), LifeScan (United States), Tidepool (United States), AgaMatrix (United States), Glooko Inc. (United States), and DarioHealth (Israel).

RECENT MARKET HAPPENINGS:

• On June 15, 2020, Abbott Laboratories received FDA clearance for its new continuous glucose meter, Freestyle Libre2. This new device is another challenger in the growing market for CGM. The new device is used in children above 4years and adults too, which is applied on the back of the upper arm. This new version adds an advantage for users in setting the alarm in people whose glucose levels are too high or low.
• On February 19, 2020, Dexcom collaborated with DreaMed to couple Dexcom continuous glucose monitors. The DreaMed Advisor is a digital solution that generates insulin delivery by investigating continuous glucose monitoring, self-monitoring blood glucose, and insulin delivery devices.
• On April 30, 2020, Roche Diagnostics announced free access for the mySugr Pro app in assisting millions of people who have diabetes to maintain their personalized daily diabetes during the COVID-19 crisis.